Diallyl sulfide enhances azoxymethane-induced preneoplasia in Fischer 344 rat colon

Chemico-Biological Interactions

Volumn 124, Issue 3, 2000, Pages 149-160

  Delker, Don A ^a   Papanikolaou, Alexandros ^a   Suhr, Young Joon ^b   Rosenberg, Daniel W ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b Seoul National University   (South Korea)

Author keywords

Aberrant crypt foci; Azoxymethane; Chemoprevention; Colon carcinogenesis; Diallyl sulfide; K ras oncogene

Indexed keywords

ALLYL SULFIDE; AZOXYMETHANE; DIMETHYLNITROSAMINE DEMETHYLASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON CANCER; CONTROLLED STUDY; DOSE RESPONSE; DRUG INTERACTION; GENE MUTATION; MALE; NONHUMAN; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PRECANCER; PROTO ONCOGENE; RAT; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ALLYL COMPOUNDS; ANIMALS; ANTICARCINOGENIC AGENTS; AZO COMPOUNDS; CARCINOGENS; COLONIC NEOPLASMS; CYTOCHROME P-450 CYP2E1; DRUG SYNERGISM; ENZYME INHIBITORS; GENES, RAS; MALE; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED F344; SULFIDES;

ANIMALIA;

EID: 0033978474     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(99)00145-3     Document Type: Article

References (42)

1. Kelloff G.J., Boone C.W., Crowell J.A., Steele V.E., Lubet R., Sigman C.C. Chemopreventive drug development: perspectives and progress. Cancer Epidemiol. Biomarkers Prev. 3:1994;85-98.
2. Greenwald P., Kelloff G.J., Boone C.W., McDonald S.S. Genetic and cellular changes in colorectal cancer: proposed targets of chemopreventive agents. Cancer Epidemiol. Biomarkers Prev. 4:1995;691-702.
3. Steele V.E., Moon R.C., Lubet R.A. et al. Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI Chemoprevention Drug Development Program. J. Cell. Biochem. Suppl. 20:1994;32-54.
4. Dorant E., van den Brandt P.A., Goldbohm R.A., Hermus R.J., Sturmans F. Garlic and its significance for the prevention of cancer in humans: a critical view. Br. J. Cancer. 67:1993;424-429.
5. Wargovich M.J. Diallyl sulfide, a flavor component of garlic (Allium sativum) inhibits dimethylhydrazine-induced colon cancer. Carcinogenesis. 8:1987;487-489.
6. Wargovich M.J., Woods C., Eng V.W., Stephens L.C., Gray K. Chemoprevention of N-nitrosomethylbenzylamine-induced esophageal cancer in rats by the naturally occurring thioether, diallyl sulfide. Cancer Res. 48:1988;6872-6875.
7. Wattenberg L.W., Sparnins V.L., Barany G. Inhibition of N-nitrosodiethylamine carcinogenesis in mice by naturally occurring organosulfur compounds and monoterpenes. Cancer Res. 49:1989;2689-2692.
8. Sparnins V.L., Barany G., Wattenberg L.W. Effects of organosulfur compounds from garlic and onions on benzo[a]pyrene induced neoplasia and glutathione S-transferase activity in the mouse. Carcinogenesis. 9:1988;131-134.
9. Dragnev K.H., Nims R.W., Lubet R.A. The chemopreventive agent diallyl sulfide: a structurally atypical phenobarbitol-type inducer. Biochem. Pharmacol. 50:1995;2099-2104.
10. Brady J.F., Dechun L., Ishizaki H., Yang C.S. Effect of diallyl sulfide on rat liver microsomal nitrosamine metabolism and other monooxygenase activities. Cancer Res. 48:1988;5937-5940.
11. Brady J.F., Wang M.-H., Hong J.-Y. et al. Modulation of rat hepatic microsomal monooxygenase activities and cytotoxicity by diallyl sulfide. Toxicol. Appl. Pharmacol. 108:1991;342-354.
12. Chang W.W.L. Histogenesis of colon cancer in experimental animals. Scand. J. Gastroenterol. 19(Suppl. 104):1984;27-44.
13. Fiala E.S. Investigations into the metabolism and mode of action of the colon carcinogens 1,2-dimethylhydrazine and azoxymethane. Cancer. 40:1977;2436-2445.
14. Papanikolaou A., Wang Q.-S., Delker D.A., Rosenberg D.W. Azoxymethane-induced colon tumors and aberrant crypt foci in mice of different genetic susceptibility. Cancer Lett. 130:1998;29-34.
15. Delker D.A., Wang Q.-S., Papanikolaou A., Whiteley H.E., Rosenberg D.W. Quantitative assessment of azoxymethane-induced aberrant crypt foci in inbred mice. Exp. Mol. Pathol. 65:1999;141-149.
16. Jeong H.G, Lee Y.W Protective effects of diallyl sulfide on N-nitrosodimethylamine-induced immunosuppression in mice. Cancer Lett. 134:1998;73-79.
17. Brady J.F., Ishizaki H., Fukuto J.M. et al. Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolises. Chem. Res. Toxicol. 4:1991;642-647.
18. Wargovich M.J., Chen C.-D., Jimenez A. et al. Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. Cancer Epidemiol. Biomarkers Prev. 5:1996;355-360.
19. McLellan E.A., Bird R.P. Aberrant crypts: potential preneoplastic lesions in the murine colon. Cancer Res. 48:1988;6187-6192.
20. McLellan E.A., Bird R.P. Specificity study to evaluate induction of aberrant crypts in murine colons. Cancer Res. 48:1988;6183-6186.
21. McLellan E.A., Medline A., Bird R.P. Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions. Cancer Res. 51:1991;5270-5274.
22. Pereira M.A., Khoury M.D. Prevention by chemopreventative agents of azoxymethane-induced foci of aberrant crypts in rat colon. Cancer Lett. 61:1991;27-33.
23. Takahashi S., Hakoi K., Yada H., Hirose M., Ito N., Fukushima S. Enhancing effects of diallyl sulfide on hepatocarcinogenesis and inhibitory actions of the related diallyl disulfide on colon and renal carcinogenesis in rats. Carcinogenesis. 13:1992;1513-1520.
24. Haber D., Siess M.-H., deWaziers I., Beaune P., Suschetet M. Modification of hepatic drug-metabolizing enzymes in rat fed naturally occurring allyl sulphides. Xenobiotica. 24:1994;169-182.
25. Haber D., Siess M.-H., Canivenc-Lavier M.-C., Le Bon A.-M., Suschetet M. Differential effects of dietary diallyl sulfide and diallyl disulfide on rat intestinal and hepatic drug-metabolizing enzymes. J. Toxicol. Environ. Health. 44:1995;423-434.
26. Vivona A.A., Shpitz B., Medline A. et al. K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane induced colon carcinogenesis. Carcinogenesis. 14:1993;1777-1781.
27. 6 alkylation by the N-nitroso carcinogens N-methyl- and N-ethyl N-nitrosourea. Mutat. Res. 250:1991;153-160.
28. Jacoby R.F., Llor X., Teng B.-B., Davidson N.O., Brasitus T.A. Mutations in the K-ras oncogene induced by 1,2-dimethylhydrazine in preneoplastic and neoplastic rat colonic mucosa. J. Clin. Invest. 87:1991;624-630.
29. Singh J., Kulkarni N., Kelloff G., Reddy B.S. Modulation of azoxymethane-induced mutational activation of ras proto-oncogenes by chemopreventive agents in colon carcinogenesis. Carcinogenesis. 15:1994;1317-1323.
30. Zaidi N.H., Pretlow T.P., O'Riordan M.A., Dumenco L.L., Allay E., Gerson S.L. Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the K-ras oncogene of mouse colon. Carcinogenesis. 16:1995;451-456.
31. Pretlow T.P. Aberrant crypt foci and K-ras mutations: earliest recognized players or innocent bystanders in colon carcinogenesis? Gastroenterology. 108:1995;600-603.
32. Takada N., Matsuda T., Otoshi T. et al. Enhancement by organosulfur compounds from garlic and onions of diethyinitrosamine-induced glutathione S-transferase positive foci in the rat liver. Cancer Res. 54:1994;2895-2899.
33. Pegg A.E. Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res. 48:1988;759-774.
34. Takano S., Matsushima M., Erturk E., Bryan G.T. Early induction of rat colonic epithelial ornithine and S-adenosyl-L-methionine decarboxylase activities by N-methyl-N-nitro-N-nitrosoguanidine or bile salts. Cancer Res. 41:1981;624-628.
35. Wolter S., Frank N. Metabolism of 1,2-dimethylhydrazine in isolated perfused rat liver. Chem. Biol. Interact. 42:1982;335-344.
36. Delker D.A., McKnight S.J., Rosenberg D.W. The role of alcohol dehydrogenase in the metabolism of the colon carcinogen methylazoxymethanol. Toxicol. Sci. 45:1998;66-71.
37. Sohn O.S., Ishizaki H., Yang C.S., Fiala E.S. Metabolism of azoxymethane, methylazoxymethanol and N-nitrosodimethylamine by cytochrome P450IIE1. Carcinogenesis. 12:1991;127-131.
38. Rosenberg D.W. Tissue specific induction of the carcinogen inducible cytochrome P450 isoform, P450IAI in colonic epithelium. Arch. Biochem. Biophys. 284:1991;223-226.
39. Rosenberg D.W., Leff T. Regulation of cytochrome P450 in cultured human colonic epithelial cells (CaCo-2). Arch. Biochem. Biophys. 300:1993;186-192.
40. Rosenberg D.W., Mankowski D. Induction of cyp2e-1 protein in mouse colon. Carcinogenesis. 15:1994;73-78.
41. Parke B., Ying L., Averill L.D., Jackman M.I., Rosenberg D.W. Cytochemical localization of a cytochrome P450 isoform, cyp2e-1, within mouse colon. Pharmacology. 50:1995;339-347.
42. Delker D.A., Bammler T., Rosenberg D.W. A comparative study of hepatic and colonic metabolic enzymes in inbred mouse lines before and after treatment with the colon carcinogen, 1,2-dimethylhydrazine. Drug Metab. Dispos. 24:1996;408-413.